NattoPharma
NattoPharma, a leading innovator in the health and nutrition industry, is headquartered in the United States, with significant operations across Europe and Asia. Founded in 2004, the company has established itself as a pioneer in the development of vitamin K2, particularly in the form of MK-7, which is derived from natto, a traditional Japanese fermented soybean dish. NattoPharma's core offerings include high-quality vitamin K2 products that support bone and cardiovascular health, setting them apart through rigorous scientific research and quality assurance. The company has achieved notable recognition in the market, positioning itself as a trusted supplier for dietary supplements and functional foods. With a commitment to advancing health through innovation, NattoPharma continues to lead the way in the vitamin K2 sector, contributing to the growing demand for natural health solutions.
DitchCarbon Score
How does NattoPharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Education Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
NattoPharma's score of 17 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
NattoPharma's reported carbon emissions
NattoPharma, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed information, it is essential to monitor NattoPharma's future disclosures regarding their climate commitments and any potential strategies they may adopt to reduce their environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
NattoPharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
